ロード中...
Prazosin for Raynaud's phenomenon in progressive systemic sclerosis
BACKGROUND: Scleroderma is a connective tissue disease causing fibrosis and commonly affects the skin and internal organs such as the GI tract, lungs, kidney and heart. Most people with scleroderma also have raynaud's phenomenon (RP). One of the possible treatment options for RP in scleroderma...
保存先:
| 出版年: | Cochrane Database Syst Rev |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley & Sons, Ltd
1998
|
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7032637/ https://ncbi.nlm.nih.gov/pubmed/10796398 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD000956 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|